The Developmental Core of the DC D-CFAR is poised to make significant contributions to the National CFAR Mission by stimulating scientific collaboration in interdisciplinary and translational research, by fostering career development of underrepresented minority and women scientists, by promoting innovative research initiatives, and by sponsoring training, development and education. This will be accomplished by maintaining a robust pilot grant award program that incorporates the community into the review of proposals (Specific Aim 1) and an active mentoring program that encompasses a Professional Development Program to support junior HIV/AIDS investigators and investigators new to HIV research, with directed focus on underrepresented minority and women scientists (Specific Aim 2). The Developmental Core Directors have been working collaboratively in functions of the HIV/AIDS Institute similar to those proposed for the DC-D-CFAR. In support of Specific Aim 1, the Core Directors have managed the HIV/AIDS Institute's mechanisms for promoting, soliciting, reviewing and awarding of pilot project grants to junior investigators and investigators new to HIV/AIDS research to better integrate HIV/AIDS research efforts across DC D-CFAR institutions. New to this mechanism will be the inclusion of members ofthe DC-D-CFAR Community Advisory Board to assist the Developmental Core Co-Directors in the review of applications;this will insure community knowledge and involvement in the direction of HIV/AIDS research in the District of Columbia. In support of Specific Aim 2, the Core Directors assessed the levels and kinds of mentoring experienced by junior investigators at DC D-CFAR institutions and produced an innovative Professional Development Program to assess, plan and monitor individual mentoring programs for junior faculty.

Public Health Relevance

. The Developmental Core is pivotal a pivotal component to the goals of the DC D-DFAR by stimulating scientific collaboration in interdisciplinary and translational research in HIV/AIDS, and by fostering career development of underrepresented minority and women scientists who can do research into HIV/AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI087714-04
Application #
8492014
Study Section
Special Emphasis Panel (ZAI1-JBS-A)
Project Start
Project End
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
4
Fiscal Year
2013
Total Cost
$82,084
Indirect Cost
$22,410
Name
George Washington University
Department
Type
DUNS #
043990498
City
Washington
State
DC
Country
United States
Zip Code
20052
Xia, Jie; Reid, Terry-Elinor; Wu, Song et al. (2018) Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis. J Chem Inf Model 58:1104-1120
Xia, Jie; Hu, Huabin; Xue, Wenjie et al. (2018) The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay. J Enzyme Inhib Med Chem 33:525-535
Pérez-Losada, Marcos; Arenas, Miguel; Castro-Nallar, Eduardo (2018) Microbial sequence typing in the genomic era. Infect Genet Evol 63:346-359
Leal, Fabio E; Menezes, Soraya Maria; Costa, Emanuela A S et al. (2018) Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-? Response in HTLV-1-Associated Neuroinflammation. Front Microbiol 9:985
Pollack, Ross A; Jones, R Brad; Pertea, Mihaela et al. (2017) Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe 21:494-506.e4
Avdoshina, Valeria; Caragher, Seamus P; Wenzel, Erin D et al. (2017) The viral protein gp120 decreases the acetylation of neuronal tubulin: potential mechanism of neurotoxicity. J Neurochem 141:606-613
Groves, Allison K; Zhan, WeiHai; Del Río-González, Ana Maria et al. (2017) Dual Incarceration and Condom Use in Committed Relationships. AIDS Behav 21:3549-3556
Castel, Amanda D; Kuo, Irene; Mikre, Meriam et al. (2017) Feasibility of Using HIV Care-Continuum Outcomes to Identify Geographic Areas for Targeted HIV Testing. J Acquir Immune Defic Syndr 74 Suppl 2:S96-S103
Jones, R Brad; Mueller, Stephanie; Kumari, Sudha et al. (2017) Antigen recognition-triggered drug delivery mediated by nanocapsule-functionalized cytotoxic T-cells. Biomaterials 117:44-53
Raposo, Rui André Saraiva; de Mulder Rougvie, Miguel; Paquin-Proulx, Dominic et al. (2017) IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight 2:e85811

Showing the most recent 10 out of 174 publications